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httcense.Abstract Background: Obscure gastrointestinal bleeding is a radiological challenge where in
almost half of the patients; the origin of the blood loss remains unexplained.
Aim: To highlight the use of dual phase CT enterography for the detection of obscured gastroin-
testinal bleed.
Patient and methods: Twenty consecutive patients (11 men and 9 women) with OGIB were included
in this study; their age ranged from 28 to 67 years (mean age 45.6 years). CT enterography was
performed ﬁrst with a non-contrast scan, followed by biphasic contrast-enhanced CT at 35 and
70 s at a rate of 4 mL/s.
Results: On CT enterography, 12 patients (60%) were negative while 8 patients (40%) had positive
ﬁndings as follows: one patient (5%) had celiac disease, 1 patient (5%) had active Crohn’s disease
and another patient (5%) had ischemic bowel changes. Five patients (20%) had small bowel neo-
plasms as follows: (1 patient had ileal angiolipoma, 1 patient had ileal hypervascular GIST, 1
patient had duodenal GIST, 1 patient had duodenal carcinoid and 1 patient had jejunal villous
adenoma).
Conclusion: MDCT enterography has a good diagnostic accuracy in the evaluation of patients with
OGIB and can reliably indicate the source of GI bleeding and guide subsequent therapy.
 2012 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
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Obscure gastrointestinal bleeding (OGIB) is deﬁned as gastro-
intestinal bleeding with no source identiﬁed at upper and lower
endoscopy (1). Despite a thorough endoscopic examination,
the origin of the blood loss remains unexplained in up to
52% of patients (1).
Investigation of the small bowel for a bleeding source can
be performed by using several modalities. Extended endoscopy
may help identify a lesion in about one third of patients but isProduction and hosting by Elsevier B.V. All rights reserved.
.10.003
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wel examinations have traditionally been a mainstay in the
evaluation of small-bowel disease but lack sensitivity in the
evaluation of OGIB (2–4).
Recently, wireless capsule endoscopy has been effectively
used in the evaluation of OGIB. The sensitivity of capsule
endoscopy ranges from 42% to 80% for detection of small-bo-
wel lesions that cause gastrointestinal (GI) bleeding (5–11).
While highly effective in the evaluation of small-bowel disease,
capsule endoscopy has technical limitations (12,13).
Computed tomographic (CT) enterography is a recently
developed diagnostic tool for the evaluation of small-bowel
disease. This technique uses multi-detector CT combined with
luminal distention of the small bowel by using neutral enteric
oral contrast material. Image acquisition after intravenous
contrast material administration is timed to optimize bowel
wall enhancement. The ability to exquisitely depict bowel wall
abnormalities, as well as extra-intestinal disease, has made it
an important tool in the evaluation of small bowel disease,
particularly inﬂammatory bowel disease (14–17).
The source of OGIB may be attributable to any number of
different causes, including missed lesions in the upper and low-
er GI tract. The age of the patient is an important factor in the
differential diagnosis of a small intestinal source of OGIB (18).A
B
Fig. 1 Celiac disease: A 35 year old male presenting with
diarrhea, malabsorption and OGIB. (A) Edematous jejunal loops
with blunted mucosal pattern. (B) Coronal: Jejunized ileal
mucosa, blunted edematous jejunal mucosa, and mesenteric
adenopathies.Determining the origin of the bleeding source in OGIB is a
challenging clinical problem. Approximately 5% of patients
presenting with GI bleeding have no source identiﬁed at eso-
phago-gastroduodenoscopy and colonoscopy; most of these
patients will have small bowel disease identiﬁed (19,20).
Small bowel vascular lesions are the most common cause.
The most common pathologic lesions in this group are angio-
dysplasias, found in 30%–60% of examinations (21). SmallB
C
Fig. 2 Active Crohn’s with SMA thrombus: A 49 year old male
presenting with obscure GI bleeding. (A) Active ileal Crohn’s
shown as water halo sign, mesenteric fat haze, and comb sign. (B)
Coronal view. (C) Sagittal: SMA thrombosis due to hypercoag-
ulability in Crohn’s.
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causing OGIB and account for about 5%–10% of cases of
small bowel bleeding (22). Other less common causes of bleed-
ing include small bowel ulcers (e.g., Crohn’s disease, use of non-
steroidal anti-inﬂammatory drugs, Meckel diverticulum), vas-
culitis, small bowel diverticula, aortoenteric ﬁstulas, and cali-
ber-persistent arteries of the stomach (Dieulafoy lesion) (23).
2. Aim of work
To highlight the use of dual phase CT enterography for detec-
tion of the cause of bleeding in obscured gastrointestinal bleed.
3. Patients and methods
3.1. Patients
Twenty consecutive patients with OGIB who were referred by
gastroenterologists at our institution for clinically indicated
dual-phase CT enterography were included in this study. The
studied group included 11 men and 9 women with their age
ranging from 28 to 67 years (mean age 45.6 years) seen during
an 8-month period between April 2011 and January 2012.
Informed consent was waived in this study. Still, conﬁden-
tiality of patients’ records is respected.A
B
Fig. 3 MVO: A 65 year old male with a history of cardiac
disease, presenting with obscure GI bleeding. (A) SMA Throm-
bus. (B) Ischemic small bowel showing water halo sign.3.2. Methods
The equipments used were:
 Toshiba Aquillon 16-MDCT unit; kV/effective mAs/rota-
tion time (s): 120 kV/225 effective mAs/0.5 s; slice thickness
of 1 mm (15 patients).
 Toshiba Aquillon 128-MDCT unit kV/effective mAs/rota-
tion time (s): 120 kV/225 effective mAs/0.35 s; slice thick-
ness of 0.5 mm (5 patients).
After a 4-h fast, patients were given a total of 1800 mL of
iso-osmotic mannitol divided into four 450-mL oral dosesA
B
C
Fig. 4 Bowel angiolipoma: A 47 year old female presenting with
abdominal pain and OGIB. (A) Luminal ileal enhancing mass
lesion. (B) Secondary intussusception. (C) Coronal.
12 M. Eid et al.given every 20 min, beginning 60 min prior to scanning. The
last dose was administered with the patient on the CT table
just prior to scanning. Anti spasmodic (visceralgine or Busco-
pan) (0.5 mg) was administered intravenously just before
intravenous contrast material injection to maximize bowel dis-
tention and minimize bowel motion artifact.
The CT examination was performed ﬁrst, with a non con-
contrast scan of the abdomen, followed by a biphasic con-
trast-enhanced CT at 35 and 70 after an injection of 120 mL
of nonionic contrast medium (350 mg I/mL) given at the ante-
cubital vein at a rate of 4 mL/s, to catch the late arterial and
portal venous phases respectively.
The data acquired were transferred to a workstation (Vitrea
or Osirix software) for multiplanar reconstruction.
4. Results
The main presenting symptoms were abdominal pain, diarrhea
and anemia.
All patients were suffering from obscure GIT bleeding
either melena, bleeding per-rectum or occult blood in the stool
with negative upper and lower GIT endoscopy.
On the performed dual phase MDCT enterography, 12 pa-
tients (60%) were negative while 8 patients (40%) had positive
ﬁndings.
Among the eight patients with positive ﬁndings, one patient
had celiac disease expressed as blunted edematous jejunal mu-
cosa, jejunized ileal mucosa and mesenteric adenopathies
(Fig. 1).A
B
Fig. 5 Hypervascular GIST: A 44 year old female presenting
with obscure GI bleeding. (A) This case highlights the hypervas-
cular nature of a GIST, shown as arterially enhancing mass lesion
related to the ileal loops at the right iliac fossa. (B) A vascular
pedicle is seen.One patient (5%) had inﬂammatory bowel disease (active
Crohn’s disease), involving a distal ileal loop not reaching
the ileo-cecal junction (so it was not visible on colonoscopy),
shown as mural thickening with mucosal hyper-enhancement
and sub-mucosal edema giving water halo sign, associated with
mesenteric fat haze, and comb sign. This was associated with
SMA thrombosis that was attributed to hypercoagulability in
Crohn’s (Fig. 2).
One patient (5%) had ischemic bowel changes with water
halo sign at an ileal loop in the right iliac fossa with occluded
SMA (Fig. 3).
Five patients (20%) had small bowel neoplasms as follows:
 One patient had ileal angiolipoma shown as intra-luminal
ileal enhancing mass lesion with secondary intussusception
(Fig. 4).
 One patient had ileal hypervascular GIST expressed as arte-
rially enhancing mass lesion related to the ileal loops at the
right iliac fossa with enhancing vascular pedicle (Fig. 5).
 One patient had duodenal GIST shown as enhancing lesion
at the third part of the duodenum.
 One patient had duodenal carcinoid expressed as heteroge-
neously enhancing lesion at the third part of duodenum that
showed central necrosis and was associated with
desmoplastic reaction at the related mesentery with
engorged mesenteric vessels.A
B
Fig. 6 Jejunal villous adenoma: A 42 year old male presenting
with obscure GI bleeding. (A) Enhancing polypoidal lesion within
the lumen of the proximal jejunum. (B) coronal.
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mal jejunum, shown as enhancing polypoidal lesion within
the lumen of the proximal jejunum (Fig. 6).
5. Discussion
The role of CT in the diagnosis of causes of gastrointestinal
bleeding continues to grow because of improvements in scan-
ning technology and favorable diagnostic outcomes in many
articles (24–28). Several studies, however, vary with the type
of scanning performed, that is single phase (3), dual phase
(4,29,30), or triple phase (2).
Our study focused on the use of dual phase CT enterogra-
phy for the detection of an obscure gastrointestinal bleed.
We included twenty patients with OGIB in the current
study, 11 men and 9 women with the age range of 28–67 years
(mean age = 45.6 years). The main presenting symptoms were
abdominal pain, diarrhea and anemia.
All patients were suffering from obscured GIT bleeding
either melena, bleeding per-rectum or occult blood in the stool
with negative upper and lower GIT endoscopy.
Eight patients (40%) had positive ﬁndings on CT enterog-
raphy while 12 patients (60%) were falsely negative.
In agreement with our results, Jain et al. (30) evaluated 21
patients with OGIB by 4 and 16-section biphasic CT enteroc-
lysis. Potential causes of GI bleeding were identiﬁed in 10 of 21
patients (47.6%).
Huprich et al. (31) studied 28 patients with OGIB using 64-
section triphasic CT enterography. They showed positive ﬁnd-
ings in 10 of 22 patients (45%).
Zhang et al. (32) compared capsule endoscopy (CE) and
16-section biphasic (arterial and 60 s delayed phases) CT enter-
ography in 123 patients (mean age 54.88 years, age range of
17–87 years) with overt OGIB. The positive rate of detection
was 30.08% for MDCT enterography and 57.72% for CE.
Moreover, the positive rate for the combined examinations
was 65.86% (81/123).
Hara et al. (33) reported on 48 patients with OGIB who
had undergone 16-section or 64-section triphasic CT enterog-
raphy. The overall sensitivity and speciﬁcity of MDCT enter-
ography were 33% and 89%, respectively. The most
common missed lesions were ulcers and vascular lesions.
Lee et al. (34) examined 65 patients with OGIB using 16-
section biphasic (arterial and 72 s delayed phases) CT enterog-
raphy, which allowed identiﬁcation of potential sources of
bleeding in 16 patients (24.6%).
In a recent report, Huprich et al. (35) described their expe-
rience in 58 patients (mean age 65 years, age range of
23–86 years) with OGIB. The sensitivity of 64-section or 128-
section triple phase CT enterography was signiﬁcantly better
than that of CE (88% vs. 38%, respectively, P= 0.008), as
it depicted more small bowel masses (100% vs. 33%, respec-
tively, P= 0.03).6. Conclusion
MDCT enterography has a good diagnostic accuracy in the
evaluation of patients with OGIB and can reliably indicate
the source of GI bleeding and guide subsequent therapy. Neg-
ative MDCT enterography results cannot reliably exclude thepresence of clinically relevant small bowel lesions as MDCT
diagnosis of superﬁcial ulcers or erosions and vascular abnor-
malities remain challenging.
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